Original Research

Real-world usage and clinical outcomes of alectinib among post-crizotinib progression anaplastic lymphoma kinase positive non-small-cell lung cancer patients in the USA

DiBonaventura MD, Wong W, Shah-Manek B, Schulz M

OncoTargets and Therapy 2018, 11:75-82

Published Date: 22 December 2017